Daniel C McFarland1, Kelly M Shaffer2, Amy Tiersten3, Jimmie Holland2. 1. Division of Network Services, Memorial Sloan Kettering Cancer Center, West Harrison, NY. Electronic address: danielcurtismcfarland@gmail.com. 2. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY. 3. Division of Hematology and Oncology, Icahn School of Medicine, New York, NY.
Abstract
BACKGROUND: Physical symptom burden and psychologic symptoms are highly prevalent in women with breast cancer. The Distress Thermometer and Problem List (DT&PL) is commonly used in oncology clinics to screen for distress and its accompanying Physical Problem List (PPL) identifies pertinent physical symptoms. OBJECTIVE: We sought to identify physical symptoms found on the PPL and evaluate whether they are associated with psychologic symptoms in women with breast cancer. METHODS: Patients (n=125) with breast cancer (Stage 0-IV) completed the DT&PL and the Hospital Anxiety and Depression Scale. They reported bother from any of 22 PPL items on the DT&PL. PPL items were assessed for their associations with distress, Hospital Anxiety and Depression Scale-anxiety, and Hospital Anxiety and Depression Scale-depression. The total number of PPL items endorsed per patient was evaluated for associations with psychologic outcomes, controlling for relevant demographic factors. RESULTS: Most physical problems were associated with depression (n = 13, 87%), and anxiety (n = 8, 53%), but fewer were associated with distress (n = 4, 27%). In multivariate analyses, a higher total number of problems was associated with younger age (p = 0.03) and more depressive symptoms (p < 0.001). CONCLUSION: Physical symptom burden detected by the DT&PL co-occurs with depression most commonly and to a lesser extent anxiety and distress in women with breast cancer. Depression is associated with more types of physical symptoms and a total number of physical symptoms. The endorsement of multiple PPL items on the DT&PL should prompt an evaluation for depression. Similarly, depression should prompt the evaluation and treatment of physical symptom burden.
BACKGROUND: Physical symptom burden and psychologic symptoms are highly prevalent in women with breast cancer. The Distress Thermometer and Problem List (DT&PL) is commonly used in oncology clinics to screen for distress and its accompanying Physical Problem List (PPL) identifies pertinent physical symptoms. OBJECTIVE: We sought to identify physical symptoms found on the PPL and evaluate whether they are associated with psychologic symptoms in women with breast cancer. METHODS:Patients (n=125) with breast cancer (Stage 0-IV) completed the DT&PL and the Hospital Anxiety and Depression Scale. They reported bother from any of 22 PPL items on the DT&PL. PPL items were assessed for their associations with distress, Hospital Anxiety and Depression Scale-anxiety, and Hospital Anxiety and Depression Scale-depression. The total number of PPL items endorsed per patient was evaluated for associations with psychologic outcomes, controlling for relevant demographic factors. RESULTS: Most physical problems were associated with depression (n = 13, 87%), and anxiety (n = 8, 53%), but fewer were associated with distress (n = 4, 27%). In multivariate analyses, a higher total number of problems was associated with younger age (p = 0.03) and more depressive symptoms (p < 0.001). CONCLUSION: Physical symptom burden detected by the DT&PL co-occurs with depression most commonly and to a lesser extent anxiety and distress in women with breast cancer. Depression is associated with more types of physical symptoms and a total number of physical symptoms. The endorsement of multiple PPL items on the DT&PL should prompt an evaluation for depression. Similarly, depression should prompt the evaluation and treatment of physical symptom burden.
Authors: Jesse R Fann; Anne M Thomas-Rich; Wayne J Katon; Deborah Cowley; Mary Pepping; Bonnie A McGregor; Julie Gralow Journal: Gen Hosp Psychiatry Date: 2008 Mar-Apr Impact factor: 3.238
Authors: Sibilah J Breen; Carl M Baravelli; Penelope E Schofield; Michael Jefford; Patsy M Yates; Sanchia K Aranda Journal: Med J Aust Date: 2009-04-06 Impact factor: 7.738
Authors: S Singer; S Kuhnt; H Götze; J Hauss; A Hinz; A Liebmann; O Krauss; A Lehmann; R Schwarz Journal: Br J Cancer Date: 2009-02-24 Impact factor: 7.640
Authors: Megan E Renna; M Rosie Shrout; Annelise A Madison; Maryam Lustberg; Stephen P Povoski; Doreen M Agnese; Raquel E Reinbolt; Robert Wesolowski; Nicole O Williams; Bhuvaneswari Ramaswamy; Sagar D Sardesai; Anne M Noonan; Jeffrey B VanDeusen; Daniel G Stover; Mathew Cherian; William B Malarkey; Michael Di Gregorio; Janice K Kiecolt-Glaser Journal: Int J Behav Med Date: 2022-07-13
Authors: Patricia I Jewett; Deanna Teoh; Sue Petzel; Heewon Lee; Audrey Messelt; Jeffrey Kendall; Dorothy Hatsukami; Susan A Everson-Rose; Anne H Blaes; Rachel I Vogel Journal: JCO Oncol Pract Date: 2020-02-24
Authors: Xin Hu; Puneet K Chehal; Cameron Kaplan; Rebecca A Krukowski; Roy H Lan; Edward Stepanski; Lee Schwartzberg; Gregory Vidal; Ilana Graetz Journal: JAMA Netw Open Date: 2021-06-01
Authors: Anna Hauffman; Sven Alfonsson; Anna Bill-Axelson; Leif Bergkvist; Marina Forslund; Susanne Mattsson; Louise von Essen; Peter Nygren; Helena Igelström; Birgitta Johansson Journal: Psychooncology Date: 2020-09-22 Impact factor: 3.894